0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Feature |  FREE
Arch Surg. 2002;137(1):113-114. doi:.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Research Letter  | 
Panniculitis in Patients Undergoing Treatment With the Bruton Tyrosine Kinase Inhibitor Ibrutinib for Lymphoid Leukemias
Stephanie K. Fabbro, MD; Sabrina M. Smith, BS; Jason A. Dubovsky, PhD; et al.
JAMA Dermatology
Original Investigation  | 
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
Martina Sanlorenzo, MD; Igor Vujic, MD; Adil Daud, MD; et al.
JAMA Dermatology
Original Investigation  | 
Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma
Giuliana Carlos, MBBS; Rachael Anforth, BMed; Arthur Clements, BSc (Med), MBBS; et al.
JAMA Internal Medicine
Original Investigation  | 
Allopurinol Use and Risk of Fatal Hypersensitivity Reactions A Nationwide Population-Based Study in Taiwan
Chien-Yi Yang, BS; Chi-Hua Chen, MS; Shin-Tarng Deng, MS; et al.